Using poisons information service data to assess the acute harms associated with novel psychoactive substances

Drug Testing and Analysis

Volumn 6, Issue 7-8, 2014, Pages 850-860

  Wood, D M ^a,b   Hill, S L ^c,d   Thomas, S H L ^c,d   Dargan, P I ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Acute toxicity; Data triangulation; Novel psychoactive substances; Poisons information service; Recreational drugs

Indexed keywords

INFORMATION SERVICES; POPULATION STATISTICS; TRIANGULATION;

ACUTE TOXICITY; CURRENT DATA; DATA TRIANGULATION; DATA-SOURCE; NOVEL PSYCHOACTIVE SUBSTANCE; ONLINE USERS; POISON CENTERS; POISON INFORMATION SERVICE; RECREATIONAL DRUGS; SERVICE DATA;

TOXICITY;

4' METHYLMETHCATHINONE; BENZOFURAN DERIVATIVE; CANNABINOID RECEPTOR AGONIST; CATHINONE; KETAMINE; METHOXETAMINE; PARACETAMOL; PIPRADOL; PSYCHOTROPIC AGENT; SYNTHETIC CANNABINOID RECEPTOR AGONIST; UNCLASSIFIED DRUG; METHAMPHETAMINE; STREET DRUG;

HUMAN; INFORMATION SERVICE; POISONS INFORMATION SERVICE; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; DRUG SURVEILLANCE PROGRAM; INTERNET;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CANNABINOID RECEPTOR AGONISTS; HUMANS; INTERNET; METHAMPHETAMINE; PSYCHOTROPIC DRUGS; STREET DRUGS;

EID: 84904578885     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1671     Document Type: Review

References (87)

1. United Nations Office on Drugs and Crime. World Drug Report 2013. Available at: http://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf [19 October 2013].
2. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2013. Available at: http://www.emcdda.europa.eu/attachements.cfm/att_213154_EN_TDAT13001ENN1.pdf [19 October 2013].
3. Drug Misuse: Findings from the 2012/13 Crime Survey for England and Wales. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/225122/Drugs_Misuse201213.pdf [19 October 2013].
4. S. Gibbons . 'Legal highs'--novel and emerging psychoactive drugs: A chemical overview for the toxicologist'. Clin. Toxicol. (Phila.) 2013, 50, 15.
5. D.M. Wood, P.I. Dargan . Novel psychoactive substances: How to understand the acute toxicity associated with the use of these substances. Ther. Drug Monit. 2012, 34, 363.
6. D.M. Wood, P.I. Dargan . Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs. J. Med. Toxicol. 2012, 8, 300.
7. D.M. Wood, P. Conran, P.I. Dargan . ICD-10 coding: poor identification of recreational drug presentations to a large Emergency Department. Emerg. Med. J. 2011, 28, 387.
8. A. Shah, D.M. Wood, P.I. Dargan . Survey of ICD-10 coding of hospital admissions due to recreational drug toxicity. QJM 2011, 104, 779.
9. Erowid Experience Vaults. Index. Available at: www.erowid.org/experiences [19 October 2013].
10. Bluelight. Trip Reports. Available at: www.bluelight.ru/vb/forums/40-Trip-Reports [19 October 2013].
11. D. Dick, C. Torrance . MixMag drugs survey. MixMag 2010, 225, 44.
12. P.I. Dargan, S. Albert, D.M. Wood . Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJM 2010, 103, 875.
13. J.R.H. Archer, P.I. Dargan, D.M. Wood, A.R. Winstock . Hospital and pre-hospital emergency service utilisation as an impact of acute recreational drug and ethanol toxicity. J. Subst. Use. 2013, 18, 129.
14. L. Regan, M. Mitchelson, C. Macdonald . Mephedrone toxicity in a Scottish emergency department. Emerg. Med. J. 2011, 28, 1055.
15. D.M. Wood, S.L. Greene, P.I. Dargan . Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg. Med. J. 2011, 28, 280.
16. P. Gee, S. Richardson, W. Woltersdorf, G. Moore . Toxic effects of BZP-based herbal party pills in humans: A prospective study in Christchurch, New Zealand. N.Z. Med. J. 2005, 118, U1784.
17. J. Simmons, L. Cookman, C. Kang, C. Skinner . Three cases of 'spice' exposure. Clin. Toxicol. (Phila.) 2011, 49, 431.
18. P.I. Dargan, R. Sedefov, A. Gallegos, D.M. Wood . The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test. Anal. 2011, 3, 454.
19. J.E. Shields, P.I. Dargan, D.M. Wood, Puchnarewicz M., S. Davies, W.S. Waring . Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation. Clin. Toxicol. (Phila.) 2012, 50, 438.
20. S.L. Hill, T. Doris, S. Gurung . Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: Case series. Clin. Toxicol. (Phila.) 2013, 51, 487.
21. J. Ramsey, P.I. Dargan, M. Smyllie, S. Davies, J. Button, D.W. Holt, D.M. Wood . Buying 'legal' recreational drugs does not mean that you aren't breaking the law. QJM 2010, 103, 777.
22. S. Davies, D.M. Wood, G. Smith, J. Button, J. Ramsey, R. Archer, D.W. Holt, P.I Dargan . Purchasing 'legal highs' on the Internet-is there consistency in what you get? QJM 2010, 103, 489.
23. S.D. Brandt, H.R. Sumnall, F. Measham, J. Cole . Analyses of second-generation 'legal highs' in the UK: initial findings. Drug Test. Anal. 2010 2, 377.
24. S.D. Brandt, S. Freeman, H.R. Sumnall, F. Measham, J. Cole . Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones. Drug Test. Anal. 2011, 3, 569.
25. M.P. Elie, L.E. Elie, M.G. Baron . Keeping pace with NPS releases: Fast GC-MS screening of legal high products. Drug Test. Anal. 2013, 5, 281.
26. P.I. Dargan, S. Hudson, J. Ramsey, D.M. Wood . The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice''. Int. J. Drug Policy 2011, 22, 274.
27. D.M. Wood, S. Davies, S.L. Greene, J. Button, D.W. Holt, J. Ramsay, P.I Dargan . Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin. Toxicol. (Phila.) 2010, 48, 924.
28. D.M. Wood, M. Puchnarewicz, A. Johnston, P.I. Dargan . A case series of individuals with analytically confirmed acute diphenyl-2-pyrrolidinemethanol (D2PM) toxicity. Eur. J. Clin. Pharmacol. 2012, 68, 349.
29. D.M. Wood, J. Button, S. Lidder, J. Ramsey, D.W. Holt, P.I Dargan . Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP). J. Med. Toxicol. 2008, 4, 254.
30. D.B. Murray, S. Potts, C. Haxton, G. Jackson, E.A. Sandliands, J. Ramsey, M. Puchnarewicz, D.W. Holt, A. Johnston, D.N. Bateman, J.W. Dear . 'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning. Clin. Toxicol. (Phila.) 2012, 50, 108.
31. M.R. Meyer, F.T. Peters . Analytical toxicology of emerging drugs of abuse - an update. Ther. Drug Monit. 2012, 34, 615.
32. World Health Organisation Global Health Observatory. World Directory of Poisons Centres - situation as of 6 February 2012. Available at: http://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html [19 October 2013].
33. The Lewin Group. Final Report on the Value of the Poisons Center. Available at: https://aapcc.s3.amazonaws.com/files/library/Value_of_the_Poison_Center_System_FINAL_9_26_2012_--_FINAL_FINAL_FINAL.pdf [19 October 2013].
34. National Poisons Information Service. Report 2012/13. Available at: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139808601 [19 October 2013].
35. A.C. Bronstein, D.A. Spyker, L.R. Cantilena, B.H. Rumack, R.C. Dart . 2011 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th annual report. Clin. Toxicol. (Phila.) 2012, 50, 911.
36. D.N. Bateman, A.M. Good, R. Afshari, C.A. Kelly . Effects of licence change on prescribing and poisons enquiries for antipsychotic agents in England and Scotland. Brit. J. Clin. Pharmacol. 2003, 55, 596.
37. P. Acheampong, G. Cooper, B. Khazaeli, D.J. Lupton, S. White, J.P. Thompson, S.H. Thomas . 'Effects of MHRA drug safety advice on time trends in prescribing volume and indices of clinical toxicity for quinine. Brit. J. Clin. Pharmacol. 2013, DOI: 10.1111/bcp.12130
38. O. Morgan, L. Hawkins, N. Edwards, P. Dargan . Paracetamol (acetaminophen) pack size restrictions and poisoning severity: Time trends in enquiries to a UK poisons centre. J. Clin. Pharm. Ther. 2007, 32, 449.
39. J.S. Fountain, D.M. Reith, M. Watts . Comparison of CD-Rom and Internet access to clinical information. Int. J. Med. Inform. 2005, 74, 769.
40. D.N. Bateman, A.M. Good . Five years of poisons information on the internet: The UK experience of TOXBASE. Emerg. Med. J. 2006, 23, 614.
41. D. James, R.D. Adams, R. Spears, G. Cooper, D.J Lupton, J.P. Thompson, S.H. Thomas . Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service. Emerg. Med. J. 2011, 28, 686.
42. R.D. Adams, D. Lupton, A.M. Good, D.N. Bateman . UK childhood exposures to pesticides 2004-2007: A TOXBASE toxicovigilance study. Arch. Dis. Child. 2009, 94, 417.
43. D.M. Wood, L. Hunter, F. Measham, P.I. Dargan . Limited use of novel psychoactive substances in South London nightclubs. QJM 2012, 105, 959.
44. MixMag. Global Drugs Survey: The Results. Available at: http://www.mixmag.net/words/features/mixmags-global-drug-survey-the-results [30 January 2014].
45. R. Hägerkvist, P. Hultén, M. Personne . Increasing Abuse of New Cathinone Derivatives in Sweden - A Poisons Centre Study for the Years 2008-2009. Clin. Toxicol. (Phila.) 2010, 48, 291.
46. D.A. James, S. Hill, P. Holmes, R. Spears, S.H.L. Thomas . Clinical characteristics of 6-(2-Aminopropyl)benzofuran ('Benzo Fury') toxicity reported to the UK National Poisons Information Service. Clin. Toxicol. (Phila.) 2011, 49, 215.
47. H.A. Spiller, M.L. Ryan, R.G. Weston, J. Jansen . Clinical experience with and analytical confirmation of 'bath salt' and 'legal highs' (synthetic cathinones) in the United States. Clin. Toxicol. (Phila.) 2011, 49, 499.
48. B. Warrick, M. Hill, B. Lehr, J. Mowry, D. Gumin, D. Anderson, M. Wahl, R. Goetz, S. Smolinske . A review of bath salt exposures reported to six regional poisons centers. Clin. Toxicol. (Phila.) 2011, 49, 567.
49. A. Rouse Dulaney . Characteristics of 'bath salt' exposures repted to a regional poison center. Clin. Toxicol. (Phila.) 2011, 49, 529.
50. E.M. Pallasch, M. Wahl, A. Burda, A. Kubic . Who uses bath salts? Urban vs. rural distribution of PCC cases. Clin. Toxicol. (Phila.) 2013, 51, 680.
51. H.A. Jolliff, C.T. Holmes, K.A. Holmes, D.C. Clifton, J.J. Jenkins . 'Bath Salts' abuse: A poison center study of the clinical effects and outcomes. Clin. Toxicol. (Phila.) 2013, 51, 678.
52. Advisory Council on the Misuse of Drugs (ACMD). Consideration of the cathinones. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/119173/acmd-cathinodes-report-2010.pdf [19 October 2013].
53. European Monitoring Centre for Drugs and Drug Addiction. EMCDDA Risk Assessments. Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances. Available at: http://www.emcdda.europa.eu/attachements.cfm/att_116646_EN_TDAK11001ENC_WEB-OPTIMISED%20FILE.pdf [19 October 2013].
54. J.X. Herbert, J.A. Tracey, E. Duggan . Bath salts and plant feeder pills: Synthetic cathinone abuse in Ireland. Clin. Toxicol. (Phila.) 2011, 49, 213.
55. National Poisons Information Service. Annual Report 2009/2010. Available at: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1284474775986 [19 October 2013].
56. D.M. Wood, S.L. Greene, P.I. Dargan . Emergency department presentations in determining the effectiveness of drug control in the United Kingdom: Mephedrone (4-methylmethcathinone) control appears to be effective using this model. Emerg. Med. J. 2013, 30, 70.
57. F. Schifano, J. Corkery, A.H. Ghodse . Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, 'meow meow') in the United Kingdom. J. Clin. Psychopharmacol. 2012, 32, 710.
58. A. Helander, O. Beck, R. Hägerkvist, P. Hultén . Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project. Scand. J. Clin. Lab. Invest. 2013, 73, 400.
59. M.B. Forrester, L. Leung, K. Kleinschmidt . Comparison of ingested versus inhaled synthetic cathinone exposures. Clin. Toxicol. (Phila.) 2012, 50, 705.
60. M.B. Forrester, L. Leung, K. Kleinschmidt . Comparison of synthetic cathinone and Methylenedioxymethamphetamine (MDMA) exposures. Clin. Toxicol. (Phila.) 2012, 50, 706.
61. C.M. Murphy, A.R. Dulaney, M.C. Beuhler, S. Kacinko . 'Bath salts' and 'Plant food' products: The experience of one regional US poisons center. J. Med. Toxicol. 2013, 9, 42.
62. B.J. Warrick, M. Hill, K. Hekman, R. Christensen, R. Goetz, M.J. Casavant, M. Wahl, J.B. Mowry, H. Spiller, D. Anderson, A. Aleguas, D. Gummin, R. Thomas, C. Neziek, S. Smolinske . A 9-state analysis of designer stimulant, 'bath salt', hospital visits reported to poisons centers'. Ann. Emerg. Med. 2013, 62, 2444.
63. K.E. Wood . Exposure to bath salts, synthetic tetrahydrocannabinol from 2009 to 2012 in the United States. J. Pediatr. 2013, 163, 213.
64. S.L. Hill, G.A. Cooper, G. Jackson, D.J. Lupton, S. Bradberry, S.H.L. Thomas . What's on the 'Spice' rack? Synthetic cannabinoid receptor agonist toxicity reported to the UK National Poisons Information Service. Clin. Toxicol. (Phila.) 2013, 51, 345.
65. D. Lonati, A. Giampreti, V. Petrolinin . Confirmation of new synthetic cannabinoids poisonings in Italy: Role of the Pavia Poison Centre in the national early warning system for drugs of abuse. Clin. Toxicol. (Phila.) 2011, 49, 199.
66. L. Cookman, C.G. Skinner, K. Von Derau, M. Miller . A retrospeecctive review of poison center calls with patients exposed to 'spice' products. Clin. Toxicol. (Phila.) 2011, 49, 531.
67. J. Plumb, W.M. McDonnell, K.T. Anderson, B.I. Crouch, M. Caravati . Adverse effects from pediatric exposures to spice (cannabinoid agonists). Clin. Toxicol. (Phila.) 2012, 50, 708.
68. C.D. Rosenbaum, A.J. Scalzo, C. Long, J.A. Weber, A. Jenkins, G.P. Lopez, S. Ragone . K2 and spice abusers: a case series of clinical and laboratory findings. Clin. Toxicol. (Phila.) 2011, 49, 528.
69. C.O. Hoyte, J. Jacob, A.A. Monte, M. Al-Jumaan, A.C. Bronstein, K.J. Heard . A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann. Emerg. Med. 2010, 60, 435.
70. Centers for Disease Control and Prevention (CDC). Notes from the field: Severe illness associated with synthetic cannabinoid use - Brunswick, Georgia. Morb. Mortal. Wkly. Rep. 2013, 62, 939.
71. L.J. Schep, R.J. Slaughter, W.A. Temple . Synthetic cannabinoid use in New Zealand: A brief evaluation of enquiries to the New Zealand National Poisons Centre. NZ Med. J. 2011, 124, 99.
72. M.B. Forrester, K. Kleinschmidt, E. Schwarz, A. Young . Synthetic cannabinoid and marijuana exposures reported to poison centers. Hum. Exp. Toxicol. 2012, 31, 1006.
73. V. Auwärter, P.I. Dargan, D.M. Wood . Synthetic cannabinoid receptor agonists, in: Novel Psychoactive Substances: Classification, Pharmacology and Toxicology. P.I. Dargan, D.M. Wood (eds). San Diego, USA, 2013, 317.
74. D. McQuade, S. Hudson, P.I. Dargan, D.M. Wood . First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. Eur. J. Clin. Pharmacol. 2013, 69, 373.
75. R. Kronstrand, M. Roman, M. Andersson, A. Eklund . Toxicological findings of synthetic cannabinoids in recreational users. J. Anal. Toxicol. 2013, 37, 534.
76. A.L. Patton, K.C. Chimalakonda, C.L. Moran, K.R. McCain, A. Radominska-Pandya, L.P. James, C. Kokes, J.H. Moran . K2 toxicity: Fatal case of psychiatric complications following AM2201 exposure. J. Forensic Sci. 2013, 58, 1676.
77. M.B. Forrester, T. Haywood . Geographic distribution of synthetic cannabinoid exposures reported to Texas Poison Centers. Am. J. Drug Alcohol Abuse 2012, 38, 603.
78. M.B. Forrester . Adolescent synthetic cannabinoid exposures reported to Texas Poison Centers. Pediatr. Emerg. Care 2012, 28, 985.
79. M.B. Forrester, K. Kleinschmidt, E. Schwarz, A. Young . Synthetic cannabinoid exposures reported to Texas poison centers. J. Addict. Dis. 2011, 30, 351.
80. M.B. Forrester, L. Leung, K. Kleinschmidt . Comparison of synthetic cannabinoid and methylenedioxymethamphetamine (MDMA) exposures. Clin. Toxicol. (Phila.) 2012, 50, 706.
81. D.M. Wood, S. Davies, M. Puchnarewicz, A. Johnston, P.I. Dargan . Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur. J. Clin. Pharmacol. 2012, 68, 853.
82. S.L. Hill, S. Harbon, J. Coulson . Methoxetamine toxicity reported to the National Poisons Information Service: clinical characteristics and patterns of enquiries (including the period of the introduction of the UK's first Temporary Class Drug Order). Emerg. Med. J. 2013, 9, 278.
83. W.L. Chan, D.M. Wood, S. Hudson, P.I. Dargan . Acute psychosis associated with recreational use of the benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis. J. Med. Toxicol. 2013, 9, 278.
84. M. White, J. Archer . Pipradrol and pipradrol derivatives, in Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, (Eds: P.I. Dargan, D.M. Wood ). San Diego, USA, 2013, 233.
85. D.M. Wood, P.I. Dargan . Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clin. Toxicol. (Phila.) 2012, 50, 727.
86. D.M. Wood, M. Puchnarewicz, A. Johnston, P.I. Dargan . A case series of individuals with analytically confirmed acute diphenyl-2-pyrrolidinemethanol (D2PM) toxicity. Eur. J. Clin. Pharmacol. 2012, 68, 349.
87. S. Lidder, P. Dargan, M. Sexton, J. Button, J. Ramsey, D. Holt, D.M. Wood . Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM]). J. Med. Toxicol. 2008, 4, 167.